Prasad’s short FDA tenure brought stricter review standards for gene and COVID vaccines, sparking biotech concern and political backlash.

Dr. Vinay Prasad had been serving as the FDA's director of the Center for Biologics Evaluation and Research since May, and ...

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / For decades, sustainability markets operated like closed clubs-built by ...

CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...

A study spearheaded by researchers at Stanford Medicine reports a substantial increase in cases of acute necrotizing ...

Vinay Prasad, a top regulator at the US Food and Drug Administration, ended his short tenure at the agency after conservative pundits including Laura Loomer and Rick Santorum led a crusade against him ...

Vinay Prasad, who headed the U.S. FDA division in charge of vaccines and was also chief medical and scientific officer, has ...

NEW YORK, NY / ACCESS Newswire / July 29, 2025 / Europe is reaching a pivotal moment in its industrial transformation. And ...

Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...

Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...

The American College of Obstetricians and Gynecologists has announced a commitment to developing and releasing maternal immunization guidance, according to a press release.In recognition of “the ...

After just a few controversial months, Vinay Prasad, MD, MPH, has stepped down as director of FDA's Center for Biologics ...